NCT00002609View on ClinicalTrials.gov

Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 1994

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Leukemia
Interventions
BIOLOGICAL

lintuzumab

DRUG

cytarabine

DRUG

idarubicin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002609 - Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission | Biotech Hunter | Biotech Hunter